Xeris Biopharma Holdings (XERS) Other financing activities (as filed) (2020 - 2026)
Xeris Biopharma Holdings (XERS) posted Other financing activities (as filed) of -$191,000 for Q2 2026, compared with -$860,000 a year earlier.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Other financing activities (as filed) (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Other financing activities (as filed) at Xeris Biopharma Holdings was -$19.23 million; for FY2025, it was -$10.88 million.
- In prior years, Xeris Biopharma Holdings' Other financing activities (as filed) was -$3.73 million in FY2024, -$2.19 million in FY2023, -$6.08 million in FY2022 and -$588,000 in FY2021.
- The Q2 2026 figure stands as the highest quarterly Other financing activities (as filed) since Q4 2024.
- According to Business Quant data, Other financing activities (as filed) for the three prior quarters was -$17.02 million (Q1 2026), -$1.54 million (Q4 2025) and -$478,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Xeris Biopharma Holdings | 2.89 Bn | 2.41 Bn | 94.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -752,000.00 |
| Jun 30, 2026 | -191,000.00 |
| Mar 31, 2026 | -17.02 Mn |
| Dec 31, 2025 | -1.54 Mn |
| Sep 30, 2025 | -478,000.00 |
| Jun 30, 2025 | -860,000.00 |
| Mar 31, 2025 | -8.00 Mn |
| Dec 31, 2024 | -166,000.00 |
| Sep 30, 2024 | -83,000.00 |
| Jun 30, 2024 | -51,000.00 |
| Mar 31, 2024 | -3.43 Mn |
| Dec 31, 2023 | -1.23 Mn |
| Sep 30, 2023 | -72,000.00 |
| Jun 30, 2023 | -25,000.00 |
| Mar 31, 2023 | -863,000.00 |
| Dec 31, 2022 | -81,000.00 |
| Sep 30, 2022 | -187,000.00 |
| Jun 30, 2022 | -200,000.00 |
| Mar 31, 2022 | -5.61 Mn |
| Dec 31, 2021 | -169,000.00 |
API Access
Xeris Biopharma Holdings Other financing activities (as filed) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();